BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Gemin X Pharmaceuticals, Inc. 

400 Chesterfield Parkway
Suite 100
Malvern  Pennsylvania  19355  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






 Company News
Cephalon, Inc. (CEPH) to Acquire Gemin X Pharmaceuticals, Inc. for $225 Million; up to $300 Million in Milestones 3/22/2011 6:42:51 AM    More...
Gemin X Pharmaceuticals, Inc. Closes $8 Million Series E Financing 8/4/2010 12:25:04 PM    More...
Gemin X Pharmaceuticals, Inc. Announces $16 Million Series D Financing 4/20/2010 6:37:01 AM    More...
Gemin X Pharmaceuticals, Inc. Completes Patient Enrollment in Phase 2 Clinical Study of Obatoclax for First-Line Treatment of Small Cell Lung Cancer 3/29/2010 9:36:13 AM    More...
Gemin X Pharmaceuticals, Inc. Initiates Phase 2 Clinical Study of Obatoclax in Combination with Standard Chemotherapy for First-Line Treatment of Small Cell Lung Cancer 3/3/2009 9:27:36 AM    More...
Gemin X Pharmaceuticals, Inc. Presents New Data on Obatoclax at the American Society of Hematology Meeting 12/9/2008 11:39:57 AM    More...
Gemin X Pharmaceuticals, Inc. Announces Data Presentations for its Novel, Targeted Cancer Therapy Obatoclax at the 50th Annual American Society of Hematology Meeting and Exposition 12/2/2008 9:39:28 AM    More...
Gemin X Pharmaceuticals, Inc. Pan Bcl-2 Inhibitor Obatoclax Demonstrates Biological and Clinical Activity in Heavily Pre-Treated Patients with Advanced Chronic Lymphocytic Leukemia 10/28/2008 11:02:55 AM    More...
Key Data Presented for Gemin X Pharmaceuticals, Inc. Programs at the 20th Annual ENA Symposium 10/24/2008 10:00:10 AM    More...
Gemin X Pharmaceuticals, Inc. to Present at the 7th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/22/2008 10:42:21 AM    More...
123

//-->